Press Releases

Press Releases

PMC press releases highlight the significance of the Coalition’s activities in education, advocacy, and evidence development.

FeaTured News
WASHINGTON, DC — The Personalized Medicine Coalition released a new report documenting the U.S. Food and Drug Administration’s continued progress in advancing personalized medicine in 2025, including the approval of […]
Read More
February 22 , 2022
Seventh Annual Edition of PMC’s Personalized Medicine at FDA Finds Field Expanding Across Disease States, Shows Personalized Medicines Accounting for More Than a Third of Newly Approved Drugs


PMC President: Newly Approved Treatments and Diagnostic Tools ‘Leave No Question’ About Emergence of Era of Personalized Medicine, Presenting Both Opportunities and Challenges for Patients and Health Systems

February 17 , 2022
Emphasizing Opportunities to Advance Personalized Medicine, PMC White Paper on Future of Health Data Calls for Policy Solutions in Key Areas


Representatives From Change Healthcare, Flatiron Health, and Tempus to Discuss Significance of Paper’s Recommendations at 12:00 p.m. ET

January 28 , 2022
As Number of Targeted Cancer Drugs Grows, Commentary in JCO Precision Oncology Proposes Expanded Definition of Clinical Utility for Genetic Testing in Cancer Care


Acknowledging Enhanced Benefits of Multi-Gene Testing, Modernized Definition Could Prompt Changes in Clinical Use of Genomic Sequencing-Based Tests

October 28 , 2021
In Move Promising to Empower More Patients to Advocate for Tailored Health Care, PMC Launches Educational Platform Designed to Encourage Patient-Provider Interactions With Attention to Biology, Circumstances, and Values


More Than a Number Platform Launches With 13 Articles on Disease Prevention, Diagnosis, and Treatment

October 6 , 2021
Study Finds Incongruities Between Drug-Gene Associations Listed in FDA’s Table of Pharmacogenetic Associations and Guidelines Published by Clinical Pharmacogenetics Implementation Consortium (CPIC)


Conflicting Information May Deter Clinicians From Ordering Hallmark Personalized Medicine Tests

March 16 , 2021
Landmark Study of Clinical Integration Efforts Among Representative Sample of US Health Care Providers Underlines Personalized Medicine’s Evolution From Concept to Reality


Multi-factorial Assessment Finds Majority of Health Care Providers Integrating Personalized Medicine into Clinical Care

February 11 , 2021
Personalized Medicines Top One-Third of All New Drug Approvals in 2020 for Third Time in Last Four Years


Report: Agency’s Policies Reinforcing Shift Toward Personalized Medicine Even in Midst of Pandemic

November 17 , 2020
New Personalized Medicine Report Shows Record-Setting Growth to 286 in Number of Personalized Medicines Available, Documents Challenges in Regulation, Reimbursement, Clinical Adoption
September 29 , 2020
Expanding Scope of Educational Initiatives, PMC Releases Infographic Encouraging Patients to Consider 22 Questions About Personalized Medicine When Conversing With Health Care Professionals
August 21 , 2020
New Patient-Centered Research Agenda for Personalized Medicine Outlines 45 Questions Across Nine Areas With Emphasis on Improving Education, Access
August 7 , 2020
New Report Underlines Inconsistent Use of Genomic Testing in US Even Among States With Favorable Coverage Policies


Understanding Genomic Testing Utilization and Coverage in the US Points to Broader Range of Administrative, Educational, Technical Challenges Complicating Efforts to Integrate Genomic Testing into Clinical Work Streams

June 10 , 2020
For Research Underpinning Novel Personalized Cancer Treatments, Personalized Medicine Coalition Announces Carl June as Recipient of 16th Annual Leadership in Personalized Medicine Award


Treatments Underscore Promise of New Era in Personalized Medicine Characterized by Ability to Alter Molecular Characteristics of Patients’ Own Cells